Pusiness Plan

SynaptiCare AI is a Texas-based healthcare technology company founded by Deawn Md Alimozzaman, an engineering leader with more than 15 years of experience in building secure, scalable, and AI-driven platforms. The company operates in the AI-powered healthcare diagnostics and patient monitoring industry, with a focus on strengthening U.S. medical resilience through advanced technology.Our business model combines B2B SaaS solutions with service partnerships across hospitals, clinics, telehealth providers, rehabilitation centers, and elder care facilities.

Company Focus

Assistive AI for elder & rehab care,

offering voice, vision, and motion-tracking support.

AI diagnostic support

for radiology, pathology, and lab data.

Remote patient monitoring

that integrates IoT devices with AI for real-time insights.

Medical data integration & analytics

to unify fragmented EHR and wearable data.

Workflow optimization tools

that enhance scheduling, triage, and patient engagement.

Target Market

Our services are designed for a wide range of healthcare stakeholders, including:

flag, american, u s, america, american, american, american, american, american

U.S. hospitals and outpatient clinics

An elderly man participates in a telemedicine session using a tablet.

Telemedicine and digital health startups

A woman lying in a hospital bed in a bright, softly lit room, appearing to rest or recover.

Rehabilitation and elder care facilities

Phase-Wise Growth Plan (2025–2028)
Close-up of a scientist examining samples under a microscope in a lab setting.
Phase I (2025–2026): Research & Prototyping

Develop AI triage and monitoring MVPs, run pilots with Texas clinics, and secure NIH/NSF grants.

Smiling businesswoman in white shirt guiding her team in a modern office environment.
Phase III (2026–2027): Incorporation & Workforce Expansion

Incorporate in Texas, ensure HIPAA/FDA compliance, hire engineers and data scientists, and launch the first commercial SaaS platform.

Close-up of US and China flags with US dollar bills, representing international trade and finance.
Phase V (2028): National Expansion & Export Readiness

Grow to serve 50+ hospitals and clinics, adapt for international markets, and publish a national healthcare impact report.

A businessman shakes hands with a pilot inside a luxurious private jet cabin.
Phase II (2026): Pilot Deployments & Partnerships
Philosophers and academics have debated morality and ethics for millennia. Guidelines like the Potter Box have create help people inform ethical decisions. But the lack regular and sustained most discussion photo community industry largely rendered the philosophical musings moot.
A detailed view of hands holding a vintage compass, suggesting exploration and guidance.
Phase IV (2027): Diversification & Federal Alignment

Expand services into elder care and predictive chronic disease risk, secure CMS/HHS contracts, and scale to rural health providers.

Targeted Outcomes by 2028

By 2028, SynaptiCare AI aims to achieve a measurable national impact by expanding its services to more than 50 hospitals, clinics, and telehealth providers across the United States. The company is committed to creating 20–30 high-skilled U.S. jobs, contributing to workforce growth in the healthcare technology sector. In parallel, SynaptiCare AI plans to secure over $2 million in federal research and innovation grants from organizations such as NIH, NSF, and SBIR/STTR programs. With its AI-driven solutions, the company is targeting a 25% reduction in diagnostic delays, directly improving patient care and provider efficiency. Beyond national impact, SynaptiCare AI will also be ready for international expansion, with systems adapted for healthcare markets in the EU, Japan, and South Asia.

Close-up of a healthcare worker holding a stethoscope, showcasing medical professionalism.

Take the first step today let’s build the future together.

Contact Us
Scroll to Top